FDA Approves New Treatment for Certain Myelodysplastic Syndromes
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved a new drug, imetelstat (Rytelo), developed by Geron Corporation. This medication is designed for adults with certain types of …
FDA Approves New Treatment for Certain Myelodysplastic Syndromes Read More